Similar overall survival with reduced vs. standard dose bevacizumab monotherapy in progressive glioblastoma.
Gleeson JP, Keane F, Keegan NM, Mammadov E, Harrold E, Alhusaini A, Harte J, Eakin-Love A, O'Halloran PJ, MacNally S, Hennessy BT, Breathnach OS, Grogan L, Morris PG.
Gleeson JP, et al. Among authors: alhusaini a.
Cancer Med. 2020 Jan;9(2):469-475. doi: 10.1002/cam4.2616. Epub 2019 Nov 22.
Cancer Med. 2020.
PMID: 31756059
Free PMC article.
Clinical Trial.